- Ownership hops held
- 47
An absent edge means not yet observed — never does not exist.
Outlook Therapeutics, Inc.
Outlook Therapeutics, Inc. — US company (sec:0001649989). UBO chain traced 47 hops, 11 owners. Every claim linked to its source.
Ownership resolves 47 hops deep toward the ultimate beneficial owner.
Investigative lead by resolved identity, not a legal determination.
Ownership & control
Links are shown as observed in a source registry — we do not currently hold ownership end dates, so a link here may since have ended. Each row carries its source; check it before relying on currency.
- Outlook Therapeutics, Inc.
None in current sources.
47-step ownership / control trace to the ultimate beneficial owner — cited at every hop. Unlock the full chain.
Everything we hold on this subject, for one price — every hop to the ultimate owner, filing history, sanctions exposure, and the asset layer (property, vessels, aircraft) — as PDF and JSON, every claim linked to its source.
Everything we hold on Outlook Therapeutics, Inc., resolved and sourced — yours to keep, no subscription.
- UBO trace
- Branded PDF + un-redacted JSON · every claim linked to its source
- Re-download for 90 days
UBO trace
Guest checkout · email only · re-download 90 days. Or subscribe from €99.
4 items you can read right now — no account, no payment.
- Identity, address & registry profile
- Sanctions & watchlist detail
- Direct connections (1 hop)
- Community notes
2 more items, hidden until you unlock this dossier. The badge on each row names the dossier that includes it.
- Full ownership trace to the UBODOSSIER
- Full export (PDF + un-redacted JSON) & change alertsDOSSIER
People & control
15 parties · 0 currentEvery officer, person with significant control and cross-company role we hold, resolved into one entry per party. Roles are registry records, not a claim of control.
- Brady Todd CAlso holds roles at 5 other companies
- Aldeyra Therapeutics, Inc.officer
- Evoke Pharma Incdirector
- Aldeyra Therapeutics, Inc.director
- CANUTE SCOTT AAlso holds roles at 7 other companies
- ELI LILLY & Coofficer
- ONCORUS, INC.director
- FLEXION THERAPEUTICS INCdirector
- DYRNESS ALBERT D.Also holds roles at 2 other companies
- HYPERLIQUID STRATEGIES INCdirector
- Sonnet BioTherapeutics Holdings, Inc.director
- Gangolli Julian SAlso holds roles at 4 other companies
- Revance Therapeutics, Inc.director
- Krystal Biotech, Inc.director
- GW PHARMACEUTICALS PLCofficer
- Haller Julia AAlso holds roles at 3 other companies
- BRISTOL MYERS SQUIBB COdirector
- EYENOVIA, INC.director
- CELGENE CORP /DE/director
- HILZINGER KURT JAlso holds roles at 3 other companies
- HUMANA INCdirector
- Cencora, Inc.director
- Cencora, Inc.officer
- KENYON LAWRENCE AAlso holds roles at 5 other companies
- NEOPHARM INCofficer
- ARNO THERAPEUTICS, INCofficer
- ALFACELL CORPofficer
- MOHAN PANKAJAlso holds roles at 3 other companies
- Sonnet BioTherapeutics Holdings, Inc.director
- Sonnet BioTherapeutics Holdings, Inc.officer
- Sonnet BioTherapeutics Holdings, Inc.tenpercentowner
- THURMAN RANDY HAlso holds roles at 10 other companies
- THERMO BIOMEDICAL INCdirector
- THERMO BIOMEDICAL INCofficer
- TFF PHARMACEUTICALS, INC.director
15 parties · 0 current. Ceased and resigned records are retained as history.
Common questions
- Who owns Outlook Therapeutics, Inc.?
- What is Outlook Therapeutics, Inc.'s risk level?
- Where does Outlook Therapeutics, Inc. appear across sources?
Community intel
Crowd leads · unverifiedIs this your company?
Open the inbox for this record, read what has been put to it, and answer on the record. You will be asked to show that you can act for Outlook Therapeutics, Inc. — nothing is disclosed before that.